Fig. 1From: Lymphocyte-sparing effect of stereotactic body radiation therapy compared to conventional fractionated radiation therapy in patients with locally advanced pancreatic cancerMedian (95% CI) TLCs reduction over time in patients treated with CFRT/CMT (Blue), SBRT/CMT (orange), and SBRT/NFV (gray)Back to article page